#hearttx search results
The #ISHLT-endorsed 2026 THT Conference (@crfheart) is taking place next month in Boston. 🫀 Attend to discover the latest heart failure innovations: 🔗 bit.ly/4rudUem #THT2026 #HeartTx #HeartFailure
New paper in #JACCHF by Drs. @StrattonTolmie, @WF_Parker, et al discusses the net survival benefit of the 2018 #HeartTx allocation system One definitive success: improved allocation to higher acuity pts vs prior system More work to be done! 🔗 jacc.org/doi/10.1016/j.… @UChicago
🚨 Submit your papers on primary graft dysfunction (#PGD) to @TheJHLT. 🫀🫁 Submissions will be accepted until 📆 28 February. #CallforPapers #HeartTx #LungTx
Interested in researching #innovations for improving outcomes for #pediatric #HeartTx recipients? 🚼🔎 Apply to the #ISHLT + #EnduringHearts, Pediatric Heart Transplantation Innovation Challenge Grant. ⠀⠀ ✍️📅 Submit your application by 20 January. Get more information at 🔗
Six-month post-transplant survival of heart donation after circulatory death using an extracorporeal perfusion system was noninferior to standard donation after brain death using traditional cold storage. Read more on the study: bit.ly/3N2rWka #Hearttx
Join @NateraGenetics for a one-hour webinar highlighting how the innovations of #ddcfDNA + #DQS improve detection of rejection, reduce reliance on invasive biopsies, & pave the way for more personalized patient management. #HeartTx 🫀📆 Free to register: 🔗
⏰ It's the last weekend to work on your #ISHLT2026 abstract submission! Don't delay - act now and get your submission in before Tuesday, 14 October at 11:59 p.m. EDT/03:59 UTC. 📝🫀🫁 Learn more at 🔗 bit.ly/4dLYGdn #HeartTx #LungTx #MCS #PVD #research #HeartFailure
#JACCHF review observes that many donor risk factors that are deemed “high-risk” do not necessarily always adversely affect post-HT outcomes, but are in fact nuanced & interact with other donor & recipient risk factors. Get the details: jacc.org/doi/10.1016/j.… #Hearttx
A state-of-the-art review on the impact of the 2018 United Network for Organ Sharing heart transplant policy changes on patient outcomes was recently published in #JACCHF. Read the key points from the review: bit.ly/3NyrXOW #Hearttx
Early Initiation of PCSK9 inhibition with alirocumab ➕ statin therapy safely lowered LDL-C in #Hearttx patients, but didn’t ⬇️ coronary artery plaque progression, based on CAVIAR findings presented at #AHA25. Read more: bit.ly/444cwVZ #HeartFailure #CardioX
The shift towards LVAD-first strategy in younger adults indeed opens compelling discussions. While the survival outcomes seem promising, what about the quality of life and long-term management aspects compared to #HeartTx? Is there enough data on complications or functional
Measuring donor LVM with the use of #cvEcho may provide a more accurate method for donor-recipient heart size matching that could improve heart transplant outcomes, especially in obese recipients 💡 jacc.org/doi/10.1016/j.… #JACCHF #Hearttx #echofirst
Various innovations in the field of preservation have helped to expand opportunities for transplant. The image 👇 highlights some of these advances. Read more about preservation techniques & new technologies in transplantation: bit.ly/41Ju9d9 #CardiologyMag #Hearttx
What’s the role of coronary microvascular dysfunction post-heart transplantation? This #JACCINT analysis demonstrated increased risk of acute rejection and death in those with abnormal #MRR: jacc.org/doi/10.1016/j.… #Hearttx
Developed with the use of #AI, FactorECG may predict the combined clinical endpoint of death, #hearttx, or LVAD implantation, significantly outperforming QRSAREA and guideline #ECG criteria. Read more about the study here: bit.ly/3KKIrSI #cvEcho
The #ISHLT-endorsed 2025 Middle East Advanced Heart Failure & Transplant Conference is taking place next week in Abu Dhabi, UAE. Join global cardiologists to connect, learn, & empower each other. 🫀 Learn more about the event: 🔗 bit.ly/3TA1UsF #MEAHFT2025 #HeartTx
In this #JACCBTS research letter, Dr. Lillian Kang et al. provide data from their experience with partial heart transplant in piglets as an alternative to homografts for valve replacement. jacc.org/doi/10.1016/j.… #Hearttx #CHD #BasicScience #TranslationalScience
A new great webinar of #ISHLT about infectious complications after thoracic transplantation will be held on 27 June, 2024 3:00 p.m. EDT! Don't miss it! ishlt.org/event-calendar… @ISHLT @ISHLTPres #LungTx #HeartTx #MedTwitter #PathTwitter
Important results for all Heart Failure Specialists just published in @JACCJournals #JACCHF! An #LVAD first strategy showed comparable outcomes to #HeartTx in adults under the age of 50 years. With organ shortages limiting transplantations, these data are encouraging! 🫀Read more
Contemporary data suggest that durable #LVAD therapy may offer survival outcomes comparable to #HeartTx in adults <50 yrs of age. These findings support the consideration of an LVAD-first strategy in selected patients. jacc.org/doi/10.1016/j.… #JACCHF
The shift towards LVAD-first strategy in younger adults indeed opens compelling discussions. While the survival outcomes seem promising, what about the quality of life and long-term management aspects compared to #HeartTx? Is there enough data on complications or functional
Contemporary data suggest that durable #LVAD therapy may offer survival outcomes comparable to #HeartTx in adults <50 yrs of age. These findings support the consideration of an LVAD-first strategy in selected patients. jacc.org/doi/10.1016/j.… #JACCHF
The 2026 ISHLT Consensus Statement for cardiac #xenotransplantation: the scientific, clinical, and regulatory blueprint, moving pig-to-human #HeartTx from possibility to disciplined progress, carefully, ethically, and globally. 🔗: jhltonline.org/article/S1053-…
Attend the #ISHLTraineeWorkshop in Toronto. 💡 📅 Tuesday, 21 April ➡️ Explore the program + register: 🔗 bit.ly/47ctHGF 🏠 All registrants will be reimbursed for a one-night hotel stay. #EarlyCareer #HeartTx #LungTx #transplantation #ISHLT2026
⏰ It's the last weekend to work on your #ISHLT2026 abstract submission! Don't delay - act now and get your submission in before Tuesday, 14 October at 11:59 p.m. EDT/03:59 UTC. 📝🫀🫁 Learn more at 🔗 bit.ly/4dLYGdn #HeartTx #LungTx #MCS #PVD #research #HeartFailure
Join @NateraGenetics for a one-hour webinar highlighting how the innovations of #ddcfDNA + #DQS improve detection of rejection, reduce reliance on invasive biopsies, & pave the way for more personalized patient management. #HeartTx 🫀📆 Free to register: 🔗
In this UNOS analysis, increased duration (> 2 years) of pre-transplant HeartMate III #VAD support was associated with increased rate of post-transplant dialysis and post-transplant mortality among adult patients. @Bilgili_Ahmet_ @OmarSharaf @fabianjimenez_ #HeartTx #MCS 🔗:
Assessment of #RWMA in donor hearts Could this help inform increased use of donor hearts with RWMA and help alleviate scarcity in the donor pool? jacc.org/doi/10.1016/j.… #JACCHF #HeartTx #HeartFailure
In a retrospective study of 4,668 adult deceased organ donors after brain death managed in US donor care units (DCUs), #HeartTx survival & heart donation were similar between hospital-based and independent DCUs (even after adjustment). 🫀 @PennLDI 🔗: jhltonline.org/article/S1053-…
jhltonline.org
Heart donation and transplant recipient survival outcomes from deceased organ donors managed in...
Despite growing prevalence, the impact of centralized deceased organ donor care units on heart donation and transplant recipient outcomes remains unknown.
Donation after circulatory death without thoracoabdominal normothermic regional perfusion or commercial ex situ perfusion systems is possible using a novel technique – rapid recovery with extended ultraoxygenated preservation. More: bit.ly/44XPf7W #CardioX #Hearttx
Controlled hypothermic preservation of donor hearts shows beneficial time-dependent variability in protein expression that may confer improved organ quality at the time of transplantation @SmidtHeart cc @ahajduczok #HeartTx 🫀 🔗: jhltonline.org/article/S1053-…
Will The Real High Risk Heart Transplant Recipients Please Stand Up? Check out this #JHLT Editorial by Drs. Jain and Kransdorf. #HeartTx 🔗: jhltonline.org/article/S1053-…
jhltonline.org
Will the real high-risk heart transplant recipients please stand up?
The development of de novo donor-specific antihuman leukocyte antibodies (dnDSA) is a well-established risk factor for antibody mediated rejection (AMR), allograft dysfunction, and death after heart...
New paper in #JACCHF by Drs. @StrattonTolmie, @WF_Parker, et al discusses the net survival benefit of the 2018 #HeartTx allocation system One definitive success: improved allocation to higher acuity pts vs prior system More work to be done! 🔗 jacc.org/doi/10.1016/j.… @UChicago
Have you listened to the latest #ISHLTVoices podcast? ⤵️ Two notable transplant cardiologists explore the evolving landscape of post-#HeartTx care in this episode presented by @NateraNeph. 🫀🎧
Check out this #ISHLTVoices podcast episode, presented by @NateraNeph, on the evolution of #ddcfDNA testing and noninvasive rejection monitoring post-#HeartTransplantation. 🫀 🎧 LISTEN NOW at 🔗 bit.ly/4lnW9K2, Spotify, Apple Podcasts 🎧 #DQS #ProsperaHeart
Donation after circulatory death #Hearttx is less likely in women than men, new research shows. Learn more with @CardioAdvisor: bit.ly/4ePxhcp
The 2018 U.S. heart allocation policy change has resulted in an increased survival benefit of heart transplantation due to improved stratification and prioritization of transplant candidates. Learn more: bit.ly/4lFCINc #Hearttx #JACCHF
Have you checked out the latest #ISHLT Standards + Guidelines? 🔎📖 Two recently published documents cover: 🫀 Antibodies and #AMR in #HeartTx 🫁 Postoperative considerations on the perioperative use of #ECLS in #LungTx View these + more at 🔗 bit.ly/45YUzbq
In this analysis of UNOS data, patients bridged with #LVAD to #DCD #HeartTx exhibited reduced early post-transplant survival compared to those without LVAD. Post-transplant outcomes were associated with clinical acuity and LVAD type. 🫀 @Yeahwa_Hong 🔗: jhltonline.org/article/S1053-…
New research suggests women are less likely than men to receive DCD #Hearttx. Find out more: bit.ly/4694q0r
Advances in Preservation = Transplant Opportunities New innovations are expanding the possibilities for heart transplantation. From cutting-edge preservation techniques to emerging technologies, the field is evolving rapidly. 🔍bit.ly/41Ju9d9 #CardiologyMag #HeartTx #
Advances in Preservation = Transplant Opportunities New innovations are expanding the possibilities for heart transplantation. From cutting-edge preservation techniques to emerging technologies, the field is evolving rapidly. 🔍bit.ly/41Ju9d9 #CardiologyMag #HeartTx #
New paper in #JACCHF by Drs. @StrattonTolmie, @WF_Parker, et al discusses the net survival benefit of the 2018 #HeartTx allocation system One definitive success: improved allocation to higher acuity pts vs prior system More work to be done! 🔗 jacc.org/doi/10.1016/j.… @UChicago
Had a great time joining leading experts at ME-AHFT 2025 in Abu Dhabi to discuss innovations in heart failure management, MCS, and transplantation in the Middle East. #MEAHFT2025 #HeartTx #HeartFailure #CardiogenicShock
So proud to see our CVTx1 and CVTx2 ICU teams ready for to deliver the best care this weekend! #HeartTx #LungTx #vascularsurgery #Ladybosses #Allwomen #ECMO #Cardiothoracicsurgery #AllWeekend @ErbenYoung @MayoAnesthesia @MayoClinicCVS @MayoMedEd @MayoClinicCCM @MayoClinic
#JACCHF review observes that many donor risk factors that are deemed “high-risk” do not necessarily always adversely affect post-HT outcomes, but are in fact nuanced & interact with other donor & recipient risk factors. Get the details: jacc.org/doi/10.1016/j.… #Hearttx
Amazing introduction to heart transplant by @MaryjaneFarrMD emphasizing Heartmate 3 LVAD and the promising results of Momentum 3 trial #ASTFellows2024 #heartTx
You are all welcome to join us on wednesday at @ISHLT webinars: Bridging patients to #HeartTx on Temporary #MCS. I’ll be talking about our situation in Latam with amazing speakers and @nbrozzimd moderating. Register: ishlt.org/meetings-educa…
Measuring donor LVM with the use of #cvEcho may provide a more accurate method for donor-recipient heart size matching that could improve heart transplant outcomes, especially in obese recipients 💡 jacc.org/doi/10.1016/j.… #JACCHF #Hearttx #echofirst
Dr. Goswami from @MayoClinicCV FL sharing their experience on the use of #Impella 5.5 and BiV MCS for bridging to #HeartTx
On the #JHLT podcast, first author @Bilgili_Ahmet_ and senior author Eric I Jeng — both of the University of Florida — discuss the optimal pre-#HeartTx duration with the #HeartMate3 #LVAD. Listen wherever you get podcasts! #JHLTThePodcast #MCS #MechanicalCirculatorySupport
Assessment of #RWMA in donor hearts Could this help inform increased use of donor hearts with RWMA and help alleviate scarcity in the donor pool? jacc.org/doi/10.1016/j.… #JACCHF #HeartTx #HeartFailure
Strong kick-off #ISHLT2024 with an inspiring presentation by @btodurov on #HeartSx #HeartTx in #Ukraine. @ISHLT
The #ISHLT-endorsed 2026 THT Conference (@crfheart) is taking place next month in Boston. 🫀 Attend to discover the latest heart failure innovations: 🔗 bit.ly/4rudUem #THT2026 #HeartTx #HeartFailure
Ischemia-free beating #HeartTx is feasible and could redefine graft preservation in cardiac transplantation, enabling longer-distance transport and expanding the donor pool. jacc.org/doi/10.1016/j.… #JACCCaseReports
The 2026 ISHLT Consensus Statement for cardiac #xenotransplantation: the scientific, clinical, and regulatory blueprint, moving pig-to-human #HeartTx from possibility to disciplined progress, carefully, ethically, and globally. 🔗: jhltonline.org/article/S1053-…
Mayo Clinic #HeartTx team certainly enjoyed @ISHLT 2025. Coming back with new ideas to innovate patient care
#JACCHF honors Dr. Christian O’Donnell with the Christopher O'Connor Award for Outstanding Scholarship for his innovative research on the association of echocardiographically measured donor LV mass & 1-year outcomes after #Hearttx! 🎉 #ACC25 #TheFaceOfCardiology @CODonnell1130
In HTx recipients, pericoronary inflammation (FAI) was an independent predictor of MACEs & allograft rejection. FAI assessment could be part of CCTA analysis in routine surveillance of #Hearttx recipients jacc.org/doi/10.1016/j.… #JACCIMG #YesCCT @Ang_Sanso @pizzi_carmine
In this #JACCBTS research letter, Dr. Lillian Kang et al. provide data from their experience with partial heart transplant in piglets as an alternative to homografts for valve replacement. jacc.org/doi/10.1016/j.… #Hearttx #CHD #BasicScience #TranslationalScience
Something went wrong.
Something went wrong.
United States Trends
- 1. Secret Service N/A
- 2. Jokic N/A
- 3. President N/A
- 4. Staged N/A
- 5. Cole Allen N/A
- 6. Butler N/A
- 7. WHCD N/A
- 8. #SWY5thWin N/A
- 9. #TXT1stGrandSlam N/A
- 10. #STARDOM N/A
- 11. White House N/A
- 12. #TXT33rdWin N/A
- 13. Torrance N/A
- 14. Nuggets N/A
- 15. POTUS N/A
- 16. Ayo Dosunmu N/A
- 17. McDaniels N/A
- 18. Cole Tomas Allen N/A
- 19. Annie's Shop N/A
- 20. #Toonami N/A